SEC Form 4 · accession 0000899243-19-002654
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Fairey
Officer — See Remarks
Period of report
Feb 1, 2019
Accepted (ET)
Feb 5, 2019 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $40.99 | Feb 1, 2019 | A | 69,500 | A | — | Jan 31, 2029 | Common Stock | 69,500 | 69,500 | D |
| Restricted Stock UnitsF2 | — | Feb 1, 2019 | A | 32,500 | A | — | — | Common Stock | 32,500 | 32,500 | D |
Explanation of responses
- F1The option shall vest and become exercisable as to 25% of the option on February 1, 2020 and in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- F2Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The units shall vest in four annual installments after February 1, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.
Remarks
Executive Vice President, Chief Commercial Officer